ArticleFrontiers in immunology2025

Effective MRD clearance and long-term survival with CD19 CAR-T in pediatric B-ALL patients with MRD positivity or chemotherapy intolerance.

Yu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.